Integrated Investment Consultants LLC Takes $908,000 Position in Centene Co. (NYSE:CNC)

Integrated Investment Consultants LLC purchased a new stake in shares of Centene Co. (NYSE:CNC - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 12,066 shares of the company's stock, valued at approximately $908,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Park Place Capital Corp grew its position in Centene by 1,190.0% during the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company's stock worth $29,000 after acquiring an additional 357 shares during the last quarter. WR Wealth Planners LLC increased its stake in shares of Centene by 41.4% in the second quarter. WR Wealth Planners LLC now owns 468 shares of the company's stock worth $31,000 after buying an additional 137 shares during the period. Chris Bulman Inc bought a new stake in Centene during the 2nd quarter valued at $33,000. Riverview Trust Co boosted its position in Centene by 154.6% during the 2nd quarter. Riverview Trust Co now owns 527 shares of the company's stock valued at $35,000 after buying an additional 320 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Centene in the second quarter valued at about $36,000. Institutional investors own 93.63% of the company's stock.

Centene Price Performance

Shares of CNC stock traded up $0.02 during mid-day trading on Friday, hitting $60.37. 4,102,533 shares of the stock were exchanged, compared to its average volume of 4,037,300. The company has a market cap of $30.48 billion, a PE ratio of 10.48, a price-to-earnings-growth ratio of 0.79 and a beta of 0.49. Centene Co. has a 52-week low of $57.20 and a 52-week high of $81.42. The firm has a fifty day moving average of $66.68 and a 200 day moving average of $70.50. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64.

Insider Activity

In other Centene news, CFO Andrew Lynn Asher purchased 17,200 shares of Centene stock in a transaction on Wednesday, November 13th. The shares were bought at an average price of $58.14 per share, with a total value of $1,000,008.00. Following the purchase, the chief financial officer now directly owns 486,847 shares in the company, valued at $28,305,284.58. This trade represents a 3.66 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Sarah London acquired 4,117 shares of Centene stock in a transaction dated Friday, November 8th. The stock was purchased at an average cost of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the purchase, the chief executive officer now directly owns 667,229 shares in the company, valued at approximately $40,567,523.20. This represents a 0.62 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.33% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on CNC shares. Robert W. Baird reduced their target price on Centene from $83.00 to $66.00 and set a "neutral" rating on the stock in a research note on Friday, October 25th. Cantor Fitzgerald reissued an "overweight" rating and issued a $90.00 target price on shares of Centene in a research report on Tuesday, October 1st. Barclays decreased their price target on shares of Centene from $97.00 to $91.00 and set an "overweight" rating for the company in a research note on Tuesday, October 29th. Stephens restated an "equal weight" rating and issued a $78.00 price objective on shares of Centene in a report on Monday, August 5th. Finally, Sanford C. Bernstein lowered their target price on shares of Centene from $96.00 to $88.00 and set an "outperform" rating for the company in a report on Wednesday, October 30th. Seven analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $83.92.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.